Results 201 to 210 of about 4,697,799 (276)

How should we manage abemaciclib in the peri-operative period during secondary breast reconstruction: balancing oncologic benefit and surgical safety. [PDF]

Breast
Cazenave MG, Elahi L, Mahiou K, Bonneau C, Ammendola O, Benoit L.   +5 more
europepmc   +1 more source

Cell and Gene Therapies Manufacturing Challenges and Integrated Good Manufacturing Practices Solutions: A Lifecycle Perspective

Biotechnology and Bioengineering, EarlyView.
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga, Udisha Singh, Sachin Dattram Pawar   +2 more
wiley   +1 more source

Established and Novel Indications for Left Ventricular Unloading-When and for Whom? [PDF]

J Cardiovasc Dev Dis
Schäfer A, Pfeffer TJ, Schmack B, Bauersachs J.   +3 more
europepmc   +1 more source

From Therapeutic Drug to Xenobiotic in Cancer Repurposing: Clozapine Mechanisms, Metabolic Liabilities, and Human-Relevant Translational Approaches. [PDF]

J Xenobiot
Gouveia MJ, Vale N.
europepmc   +1 more source

Accelerating green heterocyclic synthesis: Convergence of AI, automation, and sustainable chemistry

Bulletin of the Korean Chemical Society, EarlyView.
Green heterocyclic synthesis and data‐driven tools such as AI, high‐throughput experimentation, continuous flow, and self‐driving laboratories have developed largely in parallel. This review connects them and asks how green metrics such as E‐factor and PMI might serve as explicit optimization targets rather than post‐hoc measures, toward sustainable ...
Noor Aisyah Ahmad Shah, Amirreza Mottafegh, Su‐Hyun Yoo, Jongwoon Kim, Minseon Byeon, Juhwan Noh, Yea‐Lee Lee, Jin Suk Myung, Gwang‐Noh Ahn   +8 more
wiley   +1 more source

From Stakeholder Pressure to Strategic Advantage: A Framework of Achieving Environment Sustainability Through Pathway of Carbon Neutrality

Business Strategy and the Environment, EarlyView.
ABSTRACT Businesses are increasingly striving to reduce their carbon footprint, with carbon offsetting emerging as a viable pathway towards achieving carbon neutrality. Such efforts signify a demonstrated commitment to fostering environmental sustainability and contributing to a more sustainable future.
Sanjeev Yadav, Ashutosh Samadhiya, Anil Kumar, Sunil Luthra, Krishan Kumar Pandey   +4 more
wiley   +1 more source

BMIPP Imaging in Out-of-Hospital Cardiac Arrest: Exercise-Induced Vasospastic Angina With Ventricular Fibrillation. [PDF]

JACC Case Rep
Aikawa H, Murai K, Seiki S, Sawano H, Kobayashi M, Hirooka K, Hayashi Y, Ito Y.   +7 more
europepmc   +1 more source

Technological Turbulence, Circular Economy Practices, and Digitalization as Determinants of Innovative Culture in High‐Growth Firms

Business Strategy and the Environment, EarlyView.
ABSTRACT In a business environment characterized by technological turbulence and an increasing societal demand for greater sustainability, companies seeking to enhance their growth are compelled to foster organizational cultures that promote continuous innovation.
José Bocoya‐Maline, Salustiano Martínez‐Fierro, José Aurelio Medina‐Garrido   +2 more
wiley   +1 more source

Predictors of cardiac rehabilitation completion after acute myocardial infarction in young women: the French WAMIF Registry. [PDF]

Eur Heart J Open
Piriou PG, Angoulvant T, Bouleti C, Jarry G, Cottin Y, Motreff P, Marliere S, Uhry S, Cayla G, Leurent G, Godin M, Filippi Codaccioni E, Rangé G, Eltchaninoff H, Mesnier J, Gilard M, Manzo-Silberman S.   +16 more
europepmc   +1 more source